-
/nucleus RNAseq and ATACseq, human iPSCs, Serial Block face EM, mouse genetics, biochemistry, cell signaling control, in vivo 2-photon live imaging, and translational pharmacology to peel back the layers
-
or precision health. Applicants with expertise combining advanced approaches such as stem cell technologies, genomics, optogenetics, neural activity imaging, or neural network analysis and with the use of human
-
-intensive care unit, four surgical suites, state-of-the-art interventional neuroradiology, advanced CT, MEG, PET and MR imaging facilities, specialty outpatient clinics, a day hospital, rehabilitation and
-
underlying therapeutic approaches and/or functional brain imaging (MEG, PET, fMRI, etc.) applied to addiction and psychiatric comorbidities. Individuals with expertise in combining multiple cutting-edge
-
, substance abuse research, psychoneuroendocrinology, psychoimmunology, genetics, epigenetics, advanced brain imaging, and computational and digital psychiatry. It remains a global leader in integrating cutting
-
rich history of scientific innovation with sustained expertise in psychotherapy, substance abuse research, psychoneuroendocrinology, psychoimmunology, genetics, epigenetics, advanced brain imaging, and
-
, biology, biomedical sciences, or a related field. Applicants should have a background in molecular and cellular biology techniques, stereotaxic surgery, imaging, microscopy, behavioural and statistical
-
, advanced brain imaging, and now single-cell neurobiology. It remains a global leader in integrating cutting-edge science with clinical practice to train future psychiatric researchers and clinicians. With